Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 839 results found. Search for [ serum institute of india ]

Results 1 to 21 of 839
BusinessToday.In
April 16, 2021
In a letter to Maharashtra Chief Secretary Sitaram Kunte, Renu Swarup, Secretary in Department of Biotechnology, said Haffkine Institute can manufacture the vaccine doses.


BusinessToday.In
April 14, 2021
Rahul Gandhi tweeted, citing Mahatma Gandhi's quote: 'First they ignore you. Then they laugh at you. Then they fight you. Then you win'. He also tagged a media report, saying the Centre has fast-tracked emergency approval for foreign-produced jabs.


BusinessToday.In
April 13, 2021
The vaccines which are listed in World Health Organization's (WHO) emergency use listing will also be granted emergency use approval in India.


Rashi Bisaria
New Delhi, April 13, 2021
Govt bans on-board meals in flights as Covid-19 cases riseThe Civil Aviation Ministry said on Monday that airlines are not allowed to serve meals on flights that have a duration of less than two hours in the wake of a spike in coronavirus cases in India.The ban will come into effect from April 15, the ministry said in its latest order. However, there are no curbs on inflight meals on international flights as of now.Poonawalla-led Rising Sun's acquisition of stake in Magma Fincorp gets CCI n...


BusinessToday.In
April 13, 2021
Russian Direct Investment Fund (RDIF) CEO Kirill Dmitriev added that Sputnik V's production at a larger scale will start by July 2021 with plans to produce 500 million doses


PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year


BusinessToday.In
April 13, 2021
As part of the deal, RSHPL will acquire a 60 per cent stake in Magma Fincorp, while the non-banking financial company's promoters Chamria and Poddar will acquire a 4.68 per cent shareholding


BusinessToday.In
April 12, 2021
Of around 20 coronavirus vaccines in several clinical and pre-clinical stages, Russia's Sputnik V may get SEC's nod first


Joe C Mathew
April 11, 2021
India's two approved COVID-19 vaccine makers - Serum Institute of India and Bharat Biotech - are struggling to keep pace with the increasing demand for COVID-19 vaccines within India


Reuters
April 9, 2021
\"The agreement is legally binding and served as a basis for the first-round allocation document, which has been communicated to all participating economies,\" a Gavi spokeswoman said in an email


PTI
April 9, 2021
Despite increased demand for COVID-19 vaccines in India COVAX expects to deliver doses to all participating economies that have requested vaccines in the first half of the year


BusinessToday.In
April 9, 2021
Centre's clarification comes amid an ongoing debate over the export of vaccines with some states, mostly non-BJP ruled, flagging the issue of shortage of vaccines


BusinessToday.In
April 9, 2021
The move by the national committee on adverse effects following immunisation (AEFI) has come after the European's regulator said it found rare cases of blood clots among some adult recipients who were given AstraZeneca-Oxford university's vaccine shots


PTI
April 9, 2021
A growing number of countries have either halted or limited the use of the AstraZeneca coronavirus vaccine recently over fears that it can cause serious blood clots


PTI
April 9, 2021
Treasury has confirmed that the Serum Institute of India has fully refunded us for the remaining 500,000 doses that had not been delivered to South Africa and the money is already in our bank account, Health Minister Zweli Mkhize said


Reuters
April 9, 2021
The Philippines suspended the use of AstraZeneca shots for people under age 60 after Europe's regulator said on Wednesday it found rare cases of blood clots among some adult recipients, although it still believes that the vaccine's benefits outweighed its risks


PB Jayakumar
April 8, 2021
India had administered 9,01,98,673 vaccine doses till today morning, of which eight states accounted for 60 per cent of the total doses. Maharashtra was leading with 89,49,560 doses, accounting for 9.92 per cent of total doses


BusinessToday.In
April 8, 2021
Adar Poonawalla said that SII has submitted a formal proposal for an upfront grant from the government. It is otherwise difficult to ramp up as they have already poured in thousands of crores and borrowed Rs 1,500 crore, he said


BusinessToday.In
New Delhi, April 8, 2021
Serum Institute of India CEO Adar Poonawalla on Tuesday said that the effectiveness of the Covishield vaccine rises to as much as 90 per cent if the two shots are separated by about 2.5-3 months. Speaking to India Today, Poonawalla added that no COVID-19 vaccine is preventing more than 20-30 per cent of recipients from getting the disease. He said that the vaccine acts as a shield, which prevents anyone from going to the hospital and the same applies to different virus mutations. He also said that immunity kicks in one month after taking the first dose of the Covishield vaccine. Watch the video for more.Watch More | Is Covishield safe for people with low immunity? CEO of SII replies


BusinessToday.In
New Delhi, April 7, 2021
CEO of Serum Institute of India Adar Poonawalla spoke to India Today about when the vaccination can be opened up for all. He stated that it was a difficult decision even for the government as the priority was to protect the most vulnerable people and keeping that in mind, vaccinating everyone immediately was not an option. He also shared that for the moment SII had stopped exporting vaccines considering the second wave of the virus that had gripped the nation. Indians were a priority at this hour, he added. Watch the video for more.Also Read: Centre allows COVID-19 vaccination drives at workplaces from April 11


PAGES 1 OF 42  12345